| Product Name | MF | CAS | Details |
|---|
| EBV IgG Positive Human Plasma | Details |
| KLHDC1 antibody | Details |
| Methyl [(R)-4,6-O-benzylidene-]-2,3-di-O-toluensulfonyl-a-D-glucopyranoside | C28H30O10S2 | 65556-00-5 | Details |
| 3,4-Dimethoxy-N-(2-methoxyethyl)aniline | C11H17NO3 | 1021000-38-3 | Details |
| Ethyl 2-(1-methylbenzimidazol-2-yl)-2-oxoacetate | C12H12N2O3 | 66155-91-7 | Details |
| 4-(Piperidin-3-yl)pyridine dihydrochloride | C10H15ClN2 | 143924-46-3 | Details |
| HEXIM2 antibody | Details |
| Kv3 modulator 3 | C19H18N4O3 | 1498186-01-8 | Details |
| 2,4,5,6-Tetrakis(diphenylamino)isophthalonitrile | C56H40N6 | 1846598-27-3 | Details |
| PDIA4 protein (His tag) | Details |
| Benzanilide | C13H11NO | 93-98-1 | Details |
| 4-(4-Chlorophenyl)piperazine-1-carboxamide | C11H14ClN3O | 676579-72-9 | Details |
| tert-Butyl acetate | C6H12O2 | 540-88-5 | Details |
| 1-(1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}azetidin-3-yl)-1H-1,2,3-triazole-4-carboxylic acid | C21H18N4O4 | 1511834-90-4 | Details |
| H-CAARDRGLQPKYWPGKETRL-OH | Details |
| SB 1317 | C23H24N4O | 937270-47-8 | Details |
| 1,3-dihydro-2-benzofuran-5-carboxylic acid | C9H8O3 | 933694-57-6 | Details |
| 2'-Deoxy-5'-O-DMT-N2-isobutyryl-6-thioguanosine 3-CE phosphoramidite | C44H54N7O7PS | 125698-85-3 | Details |
| 3-Phenyl-[1,2]oxazolo[5,4-b]pyridine-5-sulfonyl chloride | C12H7ClN2O3S | 1423027-63-7 | Details |
| Dns-Glu(Cys-Gly) | C22H28N4O8S2 | Details |
| NSF Blocking Peptide | Details |
| 6-Bromo-2-pyridinecarbonitrile | C6H3BrN2 | 122918-25-6 | Details |
| Methyl 2-chloro-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate | C8H6ClN3O2 | 1935429-55-2 | Details |
| Dimepranol-d6 | C5H13NO | 97964-89-1 | Details |
| 6-Methanesulfonylpyridine-3-sulfonyl chloride | C6H6ClNO4S2 | 1565047-78-0 | Details |
| 4-(3-Chlorophenoxy)butanenitrile | C10H10ClNO | 24889-07-4 | Details |
| gamma ABU-GSDALDDFDLDML-OH | Details |
| 3-Fluoro-4-(4-methylpiperazin-1-yl)benzaldehyde | C12H15FN2O | 868770-03-0 | Details |
| (3-Cyclopropyl-1-methyl-1H-pyrazol-5-yl)methanol | C8H12N2O | 1171921-06-4 | Details |
| SIVmac239 - 8 | C84H129N23O22S | Details |
| {5H,6H,7H,8H-[1,2,4]Triazolo[4,3-a]pyridin-3-yl}methanol | C7H11N3O | 1259063-08-5 | Details |
| 8-Hydroxyquinoline copper(II) | C18H12CuN2O2 | 10380-28-6 | Details |
| CA 15-3 protein | Details |
| 3-(3-Fluorophenyl)pyrrolidin-3-ol hydrochloride | 2225136-42-3 | Details |
| Butibufen | C14H20O2 | 55837-18-8 | Details |
| 2-BROMO-6-(TRIFLUOROMETHOXY)BENZALDEHYDE | C8H4BrF3O2 | 1114809-17-4 | Details |
| 2-(2,2-Dimethylpiperazin-1-yl)ethan-1-ol | C8H18N2O | 1498903-35-7 | Details |
| EMG1 antibody | Details |
| 5-Hydroxyveratric acid | C9H10O5 | 1916-08-1 | Details |
| H-YRFF-NH2 | Details |
| 3,4-Dipropoxyaniline hydrochloride | C12H20ClNO2 | 143269-30-1 | Details |
| [(1R,2E,8S,10R,11S)-6-(Acetyloxymethyl)-11-methoxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.03,7]tetradeca-2,6-dien-8-yl] 2-meth ylprop-2-enoate | C22H28O8 | 883872-71-7 | Details |
| (1S)-1-(5-Fluoropyridin-2-yl)ethan-1-ol | C7H8FNO | 1016227-97-6 | Details |
| t-Boc-aminooxy-PEG3-acid | C14H27NO8 | 1835759-82-4 | Details |
| Tenapanor hydrochloride | C50H68Cl6N8O10S2 | 1234365-97-9 | Details |
| Methyl 2-acetamido-2-deoxy-6-O-(b-D-galactopyranosyl)-a-D-glucopyranoside | C15H27NO11 | 68774-45-8 | Details |
| N-Acetyl-D-galactosamine | C8H15NO6 | 1811-31-0 | Details |
| 1-Bromo-6-chlorohexane | C6H12BrCl | 6294-17-3 | Details |
| 3-Azetidineacetic acid, 1-[(1,1-dimethylethoxy)carbonyl]-, methyl ester | C11H19NO4 | 497160-14-2 | Details |
| 1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-2-methylazetidine-2-carboxylic acid | C20H19NO4 | 610271-10-8 | Details |
| GPX7 antibody | Details |
| 4-Nitro-3-(trifluoromethyl)phenol | C7H4F3NO3 | 88-30-2 | Details |
| Parvovirus B19 Virus-Like Particles (VP2) Antigen, Recombinant | Details |
| 4-(2-Aminoanilino)pyridine | C11H11N3 | 65053-26-1 | Details |
| N1-Losartanyl-losartan | C44H44Cl2N12O | 230971-71-8 | Details |
| 1-Methyl-6-oxopiperidine-2-carboxylic acid | C7H11NO3 | 1367674-43-8 | Details |
| H-beta,beta-Dicyclohexyl-DL-Ala-OH | C15H27NO2 | 274262-70-3 | Details |
| N-[(4-Methylphenyl)methyl]cyclopropanamine hydrochloride | C11H16ClN | 935250-86-5 | Details |
| (4-chlorophenyl)-N-(2-(2-pyridylindol-3-yl)ethyl)formamide, bromide | C22H19BrClN3O | Details |
| 4-Phenylpiperidin-3-yl]methanol | C12H17NO | 105812-73-5 | Details |
| 2-(4-Bromophenyl)-3-methylbutan-2-amine hydrochloride | C11H17BrClN | 1803593-70-5 | Details |
| N-(2-Phenylethylidene)hydroxylamine | C8H9NO | 7028-48-0 | Details |
| 3-Methyl-[1,2,4]triazolo[4,3-a]pyridine-6-carbonitrile | C8H6N4 | 1354951-13-5 | Details |
| H-GDYPLEAVR^-OH | Details |
| 2-{[5-(4-tert-Butylphenyl)-4-ethyl-4H-1,2,4-triazol-3-yl]sulfanyl}acetohydrazide | C16H23N5OS | 893726-82-4 | Details |
| MSH2 Blocking Peptide | Details |
| N-(Cyclohexylmethyl)-n-methylamine HCl | C8H18ClN | 161353-93-1 | Details |
| N-Benzyl-4-methoxybenzene-1-sulfonamide | C14H15NO3S | 119059-70-0 | Details |
| GSK 232 | C21H27ClN6O3S | Details |
| H-ATEGRVRVNSAYQDK-OH | Details |
| 2,2-Dioxo-1,3-dihydro-2λ?,1-benzothiazole-6-carboxylic acid | C8H7NO4S | 1244948-84-2 | Details |
| Methyl 8-hydroxy-1,6-naphthyridine-7-carboxylate | C10H8N2O3 | 410542-68-6 | Details |
| Suc-Ala-Ala-Pro-Met-pNA | C26H36N6O9S | 72682-73-6 | Details |
| Salmonella antibody (HRP) | Details |
| TR beta antibody (Ser142) | Details |
| 4,4-Difluoropyrrolidine-2-carboxylic acid hydrochloride | C5H8ClF2NO2 | 1354949-90-8 | Details |
| (3S)-3-Amino-4-(benzyloxy)butanoic acid hydrochloride | 2225126-96-3 | Details |
| Tectol | C30H26O4 | 24449-39-6 | Details |
| 2-Bromo-1,3-difluoro-5-(trifluoromethoxy)benzene | C7H2BrF5O | 1417568-00-3 | Details |
| 5-(2-{[2-(2,5-Dioxoimidazolidin-4-yl)ethyl]disulfanyl}ethyl)imidazolidine-2,4-dione | C10H14N4O4S2 | 459818-66-7 | Details |
| EPS8L2 antibody | Details |
| 1-{2-Bromo-6-[(methylamino)methyl]phenoxy}-2-methylpropan-2-ol hydrochloride | C12H19BrClNO2 | 1797250-85-1 | Details |
| Mal-PEG8-PFE | Details |
| Apolipoprotein C2 antibody | Details |
| 2-(4-Chloro-3-methylphenyl)acetonitrile | C9H8ClN | 85470-94-6 | Details |
| 5-Chloro-2-(1H-tetrazol-5-yl)aniline | C7H6ClN5 | 54013-18-2 | Details |
| 7,7-dimethyl-1-(((3-(phenylmethoxy)(2-pyridyl))amino)sulfonyl)bicyclo[2.2.1]heptan-2-one | C21H24N2O4S | 1022784-39-9 | Details |
| MGC46336 Blocking Peptide | Details |
| Cathepsin G (77-83) | C40H59N15O12 | Details |
| 3-Methoxy-6-methyl-1,2,4-triazine | C5H7N3O | 61178-10-7 | Details |
| 5-Cyclopropyl-2H-tetrazole | C4H6N4 | 27943-07-3 | Details |
| 3-Amino-1-ethyl-6-(trifluoromethyl)-1,2-dihydropyridin-2-one | C8H9F3N2O | 1087800-63-2 | Details |
| Dipotassium phosphite 50% solution | H4KO3P | 13492-26-7 | Details |
| 2-(9-((4-Chlorophenyl)thio)-6-fluoro-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic acid | C19H15ClFNO2S | 1030017-51-6 | Details |
| L2HGDH antibody | Details |
| GALE antibody | Details |
| 2-Chloro-1-(4-{1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}piperazin-1-yl)ethan-1-one hydrochloride | C12H16Cl2N6O | 1258651-81-8 | Details |
| 3-Ethyl-3-(4-methylphenyl)pyrrolidine-2,5-dione | C13H15NO2 | 1152584-11-6 | Details |
| FUBP3 antibody | Details |
| ZDHHC21 antibody | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||